logo
welcome
Reuters

Reuters

Structure's obesity drug reduces more weight than expected in study

Reuters
Summary
Nutrition label

77% Informative

Structure Therapeutics' GSBR-1290 helped reduce weight by 6.2% on average in a mid-stage study.

The drug's once-daily oral drug is similar to Novo Nordisk's Wegovy and Eli Lilly's Zepbound .

Structure 's shares were 20% higher in premarket trading.

VR Score

89

Informative language

98

Neutral language

9

Article tone

formal

Language

English

Language complexity

47

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links